For nearly two decades, Eli has been a trusted advisor for multinational companies operating in Vietnam. Eli is the Founding Partner of YKVN’s Life Sciences Practice, as well as a Partner in both Project Finance Practice and M&A Practice. Eli has acted for Lenders and Sponsors on a number of the largest projects to reach Financial Close in Vietnam. He is presently engaged in both traditional and green energy projects in various stages of project development and financing, including more than 5 projects in Wind and Solar. Notable clients include the China Huadian Engineering Corporation in their development of Duyen Hai and 4 Wind Projects, and the Lenders of Nam Dinh 1. Eli is also recognized in Corporate and M&A for his work for Newell Brands Inc. and for his Life Sciences Practice, including his decade of work with Pfizer and other Fortune 500 Healthcare Companies.
Eli is highly regarded by clients as a problem-solver, a crisis mitigation expert, and a commercially-oriented, practical adviser, with, among other things, his ability to assist clients develop and maintain successful long-term commercial partnerships in Vietnam –or dissolve them, as instructed.
Eli originally came to Vietnam in 2003 as a Senior Research Associate with the Vietnam Program, Harvard University and led the Law and Public Policy program at the Fulbright Economics Teaching Program in Ho Chi Minh City. Before joining YKVN LLC in 2010, Eli spent more than 3 years in the Vietnam Project Finance Practice of Freshfields Bruckhaus Deringer. Eli is a fluent speaker of the Vietnamese language. He spent his first 3 years in Vietnam learning the language.
Education
Duke University School of Law, Cum Laude, J.D. (2002)
Duke Law Journal, Note Editor
Brandeis University, Magna Cum Laude, B.A. (1998)
Bar and Professional Associations
- Member in Good-Standing, North Carolina State Bar
- Registered Foreign Lawyer, Vietnam
- Senior Fellow in Law and Policy, U.S.-Vietnam Trade Council
Judicial clerckships
Honorable James A. Wynn, Circuit Judge, U.S. Court of Appeals for the Fourth Circuit (2011–2012)
Honorable Graham C. Mullen, Chief Judge, U.S. District Court for the Western District of North Carolina (2003-2004)
Healthcare & Pharmaceutical
- Regularly advise Pharma Group within the European Chamber of Commerce for approximately three years, on a wide range of regulatory and compliance issues impacting the pharmaceutical sector, as well as the latest legislative, judicial, and administrative developments in the pharmaceutical sector;
- Regularly advise Pfizer Vietnam on numerous matters related to corporate, commercial, regulatory, and compliance issues;
- Advised largest pharmaceutical MNCs on the issues relating to current/former regulations and on drug registration and stability study, marketing authorizations in Vietnam, and advised on Vietnamese employment law;
- Advised to AstraZeneca Singapore on strategic memorandum regarding legal framework and models for the local importing and exporting in Vietnam; Advised AstraZeneca in establishment of its onshore representative office and in other corporate and regulatory matters;
- Advised Bayer Vietnam Limited on compliance of preferential treatment given to domestic drugs under the Pharmaceutical Law with the principles set out under the WTO and the EU-VN FTA;
- Advised to Servier Vietnam on the legal framework to optimize local manufacturing operations in Vietnam;
- Advised a Pharma Group Member on a number of FCPA and British Anti-Bribery Act issues;
- Advised Zuellig Pharma Vietnam on employment related issues of the Vietnamese law;
- Advised Boehringer Ingelheim on various legal issues in the pharmaceutical sector, including the registration of pharmaceuticals at the Vietnam Drug Administration, compliance with anti-corruption regulations, registration of labor rules and handling of employment disputes;
- Advised Leo Pharma on certain aspects of Vietnamese employment law;
- Advised a multinational pharmaceutical company on practical dispute resolution strategies to resolving several concurrent instances of patent infringement;
- Advised Hanh Phuc International Hospital in Binh Duong on corporate, commercial, regulatory and compliance matters;
- Advised Pharmacity JSC, a company running the Pharmacity chain of pharmaceutical stores on corporate, commercial, regulatory and compliance matters;
- Advised Santeldo, a company running the V Pharno chain of pharmaceutical stores, on corporate, commercial, regulatory and compliance matters;
- Advise a Korean investor in relation to a pharmaceutical MNC’s local subsidiary to import and sell OTC products in Vietnam; and
- Advised supplement of import and distribution rights with respect to certain pharmaceutical products in their current business licenses, and obtainment of Certificates of Eligibility for Pharmaceutical Business for these clients as required by laws.
Corporate Advice and Matters
- Advised the Representative Office of Pfizer Thailand in Vietnam (hereinafter, “Pfizer Vietnam RO”) on operational and compliance issues in relation to advertising and promotions, supply and distribution contracts, and regulatory and compliance rules in Vietnam;
- Advised Emerson Network Power – Embedded Power (Vietnam) Co Ltd and its related companies, including Roxar (Vietnam) Limited, including, without limitation, on its development of a risk mitigation strategy for employment issues related to the closure of a large factory in the southern region, its lease and fit-out of a factory in Hai Phong, as well as numerous corporate and commercial matters;
- Advised Siemens AG and Siemens Vietnam on a regulatory risk assessment and risk mitigation strategies arising from an imminent public FCPA disclosure in the U.S.;
- Advised Apple Inc. on competition law implications of “maximum resale price” and “most favored customer” provisions in iPhone distribution and sales contracts in Vietnam;
- Advised HSBC Bank (Vietnam) Ltd. on ESOP design with offshore securities to mitigate legal and regulatory risks under Vietnam’s foreign exchange regulations;
- Advised HP (Vietnam) Ltd. on numerous corporate and commercial matters, including in respect of supply and distribution contracts, promotional programs and sales events, and competition law issues;
- Advised Dresdner Bank AG on the closure of its representative office in Vietnam including in respect of the termination of employment contracts and government approach;
- Advised Scottish & Newcastle on safe harbor provisions under Vietnam’s competition law that may allow for exclusive promotion agreements and similar contractual arrangements to limit the ability of distributors to sell or distribute competing brands;
- Advised HSBC Bank (Vietnam) Ltd. on regulatory scheme, legal risks, and practical strategies for dismissing employees that, among other things, violate client confidentiality;
- Advised SkyWest Airlines in the termination of four airplane leases with Air Mekong, as well as in respect of the termination and liquidation of SkyWest’s interest in the Vietnamese operating company; and
- Advised PSB College in Vietnam in connection to operational issues (change the Dean, etc.) as well as obtainment and/or amendment to certain licenses for its operation in compliance with Vietnamese regulations.
Mergers and Acquisitions Transactions
- Advised Masan Group Corporation in the restructuring and consolidation of its ownership interests over the Nui Phao Mining Project with two simultaneous transactions, one equity-linked and the other debt-lined, acquiring all the remaining interests and extinguishing all of the remaining rights of two private equity funds managed by Dragon Capital;
- Advised Nui Phao Mining Company Limited in the establishment of a joint venture mineral processing company with H.C. Stark GmbH to process and export tungsten ore concentrate sourced from the Nui Phao Mine, including the joint venture agreement, charter, tungsten supply agreement, tungsten offtake agreement, land lease agreement, and the know-how license agreement;
- Advised Caesars Entertainment Corporation in a proposed joint venture with Winvest LLC Group in the design, construction, management and operation of a hotel, entertainment and casino project in Ba Ria – Vung Tau province, including by conducting a due diligence and drafting a final report on the target company’s investment licenses, material government approvals, and then drafting several legal memoranda explaining key project risks and identifying possible avenues for mitigating such risks;
- Advised Goldman Sachs in its acquisition of 12.6% of the outstanding shares in the Diana Joint Stock Company, including in drafting and negotiating the share purchase agreement, shareholders’ agreement, call and put option agreements, and the amended charter. This deal was Goldman Sachs first private equity transaction in the Vietnamese market;
- Advised Morgan Stanley in its acquisition of a controlling stake in the Gateway Securities JSC, including in drafting and negotiating the share purchase agreement, shareholders’ agreement, call and put option agreements, and the amended charter. This deal was Morgan Stanley first private equity transaction in the Vietnamese market, as well as the first acquisition of a Vietnamese securities company by a foreign investor;
- Advised Masan Group Corporation in the US$200 million investment by Kohlberg Kravis Roberts (KKR) in Masan Consumer Corporation by a combination of primary share subscription and secondary share purchase, as well as advising on related option agreements and regulatory approvals;
- Advised PetroVietnam Exploration and Production Corporation (PVEP) in its purchase of Block 39 from ConocoPhillips in Peru;
- Advised the Sovereign wealth fund of Qatar in relation to the offshore and onshore structuring and purchase of project companies with the right to develop a high-rise resort, hotel, and residential complex near Da Nang; and
- Advised Masan Group Corporation on a US$30 million convertible loan granted by an affiliate of Goldman Sachs for the purpose of funding the development of the Nui Phao Mine’s exploitation of tungsten and other minerals.
Project Finance Transactions
- Advised KEXIM and the consortium of international lenders in connection with the US$2.2 billion international project financing for the Mong Duong 2 Power Plant, a 1,200MW coal-fired power plant developed by AES, Posco Engineering and Construction and Stable Investment Corporation;
- Advised PetroVietnam in the proposed establishment of a joint venture, and sale of existing minority interest, in the Vung Ang 1 Power Project with a Southeast Asian National Oil Company, including in respect of the share purchase agreement, shareholders’ agreement, revised corporate charter, and government approval process;
- Advised the Sumitomo Corporation / Hanoinco Consortium on risk allocation and key issues related to the scope of the government guarantee, foreign exchange, and infrastructure sharing relevant to the development of the Van Phong 2 x 660MW Coal-Fired BOT Power Project in Vietnam;
- Advised Mitsui on the structuring of ownership interests within a proposed investment consortium and the effect of such structuring on the availability of project finance on preferential terms from JICA and other lenders in relation to the O Mon-2 Combined Cycle Power Project;
- Advised International Power in the preparation of its bid proposal and its negotiation in relation to key project documents in the tender phase of the Nghi Son II 2x600MW BOT Coal-Fired Power Project in central Vietnam; and
- Advised the Vietnam-Oman Investment Fund on its subscription to a US$40 million convertible bond with a Vietnamese Public Company for the purposes of funding the construction and development of 220MW hydropower facility.
Rankings
Notable practitioner | Corporate and M&A | Asialaw | 2023, 2022, 2021, 2020
Recommended Lawyer | Corporate and M&A | Legal 500 | 2022, 2021
Recommended Lawyer | Projects | Legal 500 | 2022
Notable practitioner | Employment | Chambers | 2021
Top Pharmaceutical Adviser in Vietnam by various international and regional organizations | 2018-2021
- What Pharmaceutical MNCs need to know about Emergency Authorizations in Vietnam? Lessons learned from COVID-19 Pandemic (2023)
- Vietnam Chapter | 2022 The Healthcare Law Review | The Law Reviews – 6th Edition
- Vietnam Chapter | The Healthcare Law Review 2021 – 5th Edition (2021)
- Drug Procurement under Current Vietnamese Regulations and the EU-VN-FTA (2021)
- Vietnam Chapter | The Healthcare Law Review 2020 – 4th Edition (2020)
- Covid-19 | Extension of Market Access to Life-Saving and Life-Extending Drugs (2020)
- Covid-19 and Force Majeure in Light of Vietnamese Law and Pharmaceutical Practice (2020)
- Covid-19 and Force Majeure in Light of Vietnamese Law and Practice (2020)
- Project Finance for Vietnam’s Energy Generation Powering Growth and Finding Political Will (2019)
- Dawn Raids in Vietnam, What You Should Know (2019)
- GSP for Drugs and Drugs Materials (2019)
- “New Rules, New Game” for Pharmaceutical MNCs (2018)
- Pharmaceutical MNCs in DAV Official Letter 13439 (2018)
- Decree No. 155/2018/ND-CP on Drug Information (2018)
- Power Generation: A Case Study in the Current Legal Risks and Uncertainties of Implementing BOT Projects in Vietnam, 2 DONG-A J. INT‘L BUS. TRANS. L. 27 (2011) (with Lam Quynh Anh);
- Mergers and Acquisitions in Vietnam, Corporate Acquisitions and Mergers, Kluwer Law International (Edited by Peter F.C. Begg) (2008) (with Tony Foster);
- The Chu Lai Open Economic Zone and Rural Development: Central Planning’s Laboratory for Policy and Institutional Innovation? (2008), UNDP-DFID Working Paper Series on Vietnam’s Decentralization; and
- Mr. Nam’s Dilemma: Barriers to Private Sector Growth in Vietnam (2006) (with others), Kennedy School of Government Program in Policy Case Studies.